Hasselbalch, Hans Carl: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response.

Holmström, Morten Orebo, Riley, Caroline Hasselbalch, Skov, Vibe, Svane, Inge Marie, Hasselbalch, Hans Carl, Andersen, Mads Hald

Journal:

Year:

2018

Language:

english

File:

PDF, 2.85 MB

english, 2018

2

Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis

Silver, Richard T, Kiladjian, Jean-Jacques, Hasselbalch, Hans Carl

Journal:

Expert Review of Hematology

Year:

2013

Language:

english

File:

PDF, 942 KB

english, 2013

3

Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?

Hasselbalch, Hans Carl

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 284 KB

english, 2013

4

Eosinophilia in routine blood samples as a biomarker for solid tumor development – A study based on The Copenhagen Primary Care Differential Count (CopDiff) Database

Andersen, Christen Lykkegaard, Siersma, Volkert Dirk, Hasselbalch, Hans Carl, Lindegaard, Hanne, Vestergaard, Hanne, Felding, Peter, de Fine Olivarius, Niels, Bjerrum, Ole Weis

Journal:

Acta Oncologica

Year:

2014

Language:

english

File:

PDF, 129 KB

english, 2014

5

Frequent occurrence of anticardiolipin antibodies, Factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders

Morten Krogh Jensen, Peter de Nully Brown, Sixtus Thorsen, Hans Carl Hasselbalch

Journal:

American Journal of Hematology

Year:

2002

Language:

english

File:

PDF, 93 KB

english, 2002

6

Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin

Hans Carl Hasselbalch, Nielsaage Tøffner Clausen, Bjarne Anker Jensen

Journal:

American Journal of Hematology

Year:

2002

Language:

english

File:

PDF, 205 KB

english, 2002

7

Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan

Iben Nielsen, Hans Carl Hasselbalch

Journal:

American Journal of Hematology

Year:

2003

Language:

english

File:

PDF, 67 KB

english, 2003

8

Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis

Hans Carl Hasselbalch, Ole Weiss Bjerrum, Bjarne Anker Jensen, Nielsaage Tøffner Clausen, Per Boye Hansen, Henrik Birgens, Marianne Hamilton Therkildsen, Elisabeth Ralfkiær

Journal:

American Journal of Hematology

Year:

2003

Language:

english

File:

PDF, 68 KB

english, 2003

9

A possible role for STI571 in the treatment of idiopathic myelofibrosis

Hans Carl Hasselbalch

Journal:

American Journal of Hematology

Year:

2001

Language:

english

File:

PDF, 199 KB

english, 2001

10

Statins in the treatment of polycythaemia vera and allied disorders: An antithrombotic and cytoreductive potential?

Hans Carl Hasselbalch, Caroline H. Riley

Journal:

Leukemia Research

Year:

2006

Language:

english

File:

PDF, 156 KB

english, 2006

11

Myelofibrosis with myeloid metaplasia: The advanced phase of an untreated disseminated hematological cancer: Time to change our therapeutic attitude with early upfront treatment?

Hans Carl Hasselbalch

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 140 KB

english, 2009

12

Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders

Morten Krogh Jensen, Peter De Nully Brown, Birgit Villadsen Lund, Ove Juul Nielsen, Hans Carl Hasselbalch

Journal:

British Journal of Haematology

Year:

2000

Language:

english

File:

PDF, 356 KB

english, 2000

13

Idiopathic myelofibrosis — an update with particular reference to clinical aspects and prognosis

Hans Carl Hasselbalch

Journal:

International Journal of Clinical & Laboratory Research

Year:

1993

Language:

english

File:

PDF, 1.71 MB

english, 1993

14

B-cell depletion with rituximab—a targeted therapy for Graves’ disease and autoimmune thyroiditis

Hans Carl Hasselbalch

Journal:

Immunology Letters

Year:

2003

Language:

english

File:

PDF, 136 KB

english, 2003

15

The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders

Thomas Stauffer Larsen, Jacob Haaber Christensen, Hans Carl Hasselbalch, Niels Pallisgaard

Journal:

British Journal of Haematology

Year:

2007

Language:

english

File:

PDF, 756 KB

english, 2007

16

Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents

Waleed Ghanima, Peter Junker, Hans Carl Hasselbalch, Leonardo Boiocchi, Julia T. Geyer, Xingmin Feng, Sif Gudbrandsdottir, Attilio Orazi, James B. Bussel

Journal:

British Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 119 KB

english, 2011

17

A novel immunohistochemical sequential multi-labelling and erasing technique enables epitope characterization of bone marrow pericytes in primary myelofibrosis

Ann Madelung, Michael Bzorek, Henrik Bondo, Eva Zetterberg, Ole Weis Bjerrum, Hans Carl Hasselbalch, Stefan Scheding, Elisabeth Ralfkiaer

Journal:

Year:

2012

Language:

english

File:

PDF, 554 KB

english, 2012

18

The JAK2V617F allele burden and STAT3- and STAT5 phosphorylation in myeloproliferative neoplasms: early prefibrotic myelofibrosis compared with essential thrombocythemia, polycythemia vera and myelofibrosis

MALENE RISUM, ANN MADELUNG, HENRIK BONDO, MICHAEL BZOREK, MICHAEL HOLMSGAARD KRISTENSEN, INGER MERETE STAMP, HANS CARL HASSELBALCH

Journal:

Year:

2011

Language:

english

File:

PDF, 208 KB

english, 2011

19

Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemia

THOMAS STAUFFER LARSEN, HANS CARL HASSELBALCH, NIELS PALLISGAARD, MICHAEL BOE MØLLER

Journal:

Year:

2007

Language:

english

File:

PDF, 244 KB

english, 2007

20

A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis

Thomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, Gitte Birk Kerndrup

Journal:

Cancer Genetics and Cytogenetics

Year:

2007

Language:

english

File:

PDF, 746 KB

english, 2007

21

High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis

Hans Carl Hasselbalch, Vibe Skov, Thomas Stauffer Larsen, Mads Thomassen, Caroline Hasselbalch Riley, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 871 KB

english, 2011

22

Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area

Morten Krogh Jensen, Peter De Nully Brown, Ove Juul Nielsen, Hans Carl Hasselbalch

Journal:

European Journal of Haematology

Year:

2000

Language:

english

File:

PDF, 195 KB

english, 2000

23

Increased circulating platelet–leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count

Morten Krogh Jensen, Peter De Nully Brown, Birgit Villadsen Lund, Ove Juul Nielsen, Hans Carl Hasselbalch

Journal:

European Journal of Haematology

Year:

2001

Language:

english

File:

PDF, 315 KB

english, 2001

24

Elevated soluble urokinase plasminogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythaemia vera

Morten Krogh Jensen, Rikke Riisbro, Peter De Nully Brown, Nils Brünner, Hans Carl Hasselbalch

Journal:

European Journal of Haematology

Year:

2002

Language:

english

File:

PDF, 203 KB

english, 2002

25

Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders

Morten Krogh Jensen, Mads Nikolaj Holten-Andersen, Rikke Riisbro, Peter de Nully Brown, Maj Britt Larsen, Lars Kjeldsen, Lene Heickendorff, Nils Brünner, Hans Carl Hasselbalch

Journal:

European Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

26

Serum Prolactin and Thyrotropin Responses to Thyrotropin-Releasing Hormone in Men with Alcoholic Cirrhosis

Hans Carl Hasselbalch, Karine Bech, Dr. Peter Claes Eskildsen

Journal:

Journal of Internal Medicine

Year:

1981

Language:

english

File:

PDF, 291 KB

english, 1981

27

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis – impact on disease phenotype

Thomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, Hans Carl Hasselbalch

Journal:

European Journal of Haematology

Year:

2007

Language:

english

File:

PDF, 586 KB

english, 2007

28

Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis

Vibe Skov, Thomas Stauffer Larsen, Mads Thomassen, Caroline Hasselbalch Riley, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse, Hans Carl Hasselbalch

Journal:

European Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 175 KB

english, 2011

29

Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance

Vibe Skov, Thomas Stauffer Larsen, Mads Thomassen, Caroline Hasselbalch Riley, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse, Hans Carl Hasselbalch

Journal:

Leukemia Research

Year:

2012

Language:

english

File:

PDF, 533 KB

english, 2012

30

Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis

Vibe Skov, Mads Thomassen, Caroline H. Riley, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse, Hans Carl Hasselbalch, Thomas Stauffer Larsen

Journal:

Experimental Hematology

Year:

2012

Language:

english

File:

PDF, 660 KB

english, 2012

31

Myeloproliferative neoplasms in five multiple sclerosis patients

Thorsteinsdottir, Sigrun, Bjerrum, Ole Weis, Hasselbalch, Hans Carl

Journal:

Leukemia Research Reports

Year:

2013

Language:

english

File:

PDF, 175 KB

english, 2013

32

Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms

Christensen, Alexander Sidelmann, Møller, Jonas Bech, Hasselbalch, Hans Carl

Journal:

Leukemia Research

Year:

2014

Language:

english

File:

PDF, 576 KB

english, 2014

33

The platelet–cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?

Hasselbalch, Hans Carl

Journal:

Leukemia Research

Year:

2014

Language:

english

File:

PDF, 1.00 MB

english, 2014

34

Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death

Andersen, Christen Lykkegaard, Siersma, Volkert Dirk, Hasselbalch, Hans Carl, Lindegaard, Hanne, Vestergaard, Hanne, Felding, Peter, de Fine Olivarius, Niels, Bjerrum, Ole Weis

Journal:

American Journal of Hematology

Year:

2013

Language:

english

File:

PDF, 174 KB

english, 2013

35

Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms

Skov, Vibe, Larsen, Thomas Stauffer, Thomassen, Mads, Riley, Caroline Hasselbalch, Jensen, Morten K., Bjerrum, Ole Weis, Kruse, Torben A., Hasselbalch, Hans Carl

Journal:

Leukemia and Lymphoma

Year:

2012

Language:

english

File:

PDF, 314 KB

english, 2012

36

A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms

Hasselbalch, Hans Carl

Journal:

Expert Review of Hematology

Year:

2011

Language:

english

File:

PDF, 869 KB

english, 2011

37

Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis

Skov, Vibe, Riley, Caroline Hasselbalch, Thomassen, Mads, Larsen, Thomas Stauffer, Jensen, Morten K., Bjerrum, Ole Weis, Kruse, Torben A., Hasselbalch, Hans Carl

Journal:

Leukemia and Lymphoma

Year:

2013

Language:

english

File:

PDF, 1001 KB

english, 2013

38

Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera

Utke Rank, Cecilie, Weis Bjerrum, Ole, Larsen, Thomas Stauffer, Kjær, Lasse, de Stricker, Karin, Riley, Caroline Hasselbalch, Hasselbalch, Hans Carl

Journal:

Leukemia and Lymphoma

Year:

2015

Language:

english

File:

PDF, 1.25 MB

english, 2015

39

Interferon in polycythemia vera and related neoplasms. Can it become the treatment of choice without a randomized trial?

Hasselbalch, Hans Carl, Silver, Richard T

Journal:

Expert Review of Hematology

Year:

2015

Language:

english

File:

PDF, 264 KB

english, 2015

40

Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients

Bjørn, Mads Emil, Holmström, Morten Orebo, Hasselbalch, Hans Carl

Journal:

Leukemia and Lymphoma

Year:

2015

Language:

english

File:

PDF, 1.64 MB

english, 2015

41

Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study

Frederiksen, Henrik, Farkas, Dóra Körmendiné, Christiansen, Christian Fynbo, Larsen, Thomas Stauffer, Hasselbalch, Hans Carl, Stentoft, Jesper, Sørensen, Henrik Toft

Journal:

The Lancet Haematology

Year:

2015

Language:

english

File:

PDF, 244 KB

english, 2015

42

Perspectives on the increased risk of second cancer in patients with essential thrombocythemia, polycythemia vera and myelofibrosis

Hasselbalch, Hans Carl

Journal:

European Journal of Haematology

Year:

2015

Language:

english

File:

PDF, 169 KB

english, 2015

43

Smoking as a Contributing Factor for Development of Polycythemia Vera and Related Neoplasms

Hasselbalch, Hans Carl

Journal:

Leukemia Research

Year:

2015

Language:

english

File:

PDF, 1.33 MB

english, 2015

44

Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms

Sørensen, Anders Lindholm, Hasselbalch, Hans Carl

Journal:

Leukemia Research

Year:

2015

Language:

english

File:

PDF, 629 KB

english, 2015

45

High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden

Larsen, Thomas Stauffer, Pallisgaard, Niels, Møller, Michael Boe, Hasselbalch, Hans Carl

Journal:

Hematology (American Society of Hematology)

Year:

2008

Language:

english

File:

PDF, 123 KB

english, 2008

46

Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission

Larsen, Thomas Stauffer, Møller, Michael Boe, de Stricker, Karin, Nørgaard, Peter, Samuelsson, Jan, Marcher, Claus, Andersen, Morten T., Bjerrum, Ole Weis, Hasselbalch, Hans Carl

Journal:

Hematology (American Society of Hematology)

Year:

2009

Language:

english

File:

PDF, 604 KB

english, 2009

47

Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden

Larsen, Thomas Stauffer, Pallisgaard, Niels, de Stricker, Karin, Møller, Michael Boe, Hasselbalch, Hans Carl

Journal:

Hematology (American Society of Hematology)

Year:

2009

Language:

english

File:

PDF, 187 KB

english, 2009

48

Optimal therapy for polycythemia vera and essential thrombocythemia: Preferred use of interferon therapy based on phase 2 trials

Silver, Richard T., Hasselbalch, Hans Carl

Journal:

Hematology (Maney Publishing)

Year:

2016

Language:

english

File:

PDF, 351 KB

english, 2016

49

Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?

Elbæk, Mette Vestergaard, Sørensen, Anders Lindholm, Hasselbalch, Hans Carl

Journal:

Leukemia and Lymphoma

Year:

2016

Language:

english

File:

PDF, 830 KB

english, 2016

50

A new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms

Brochmann, Nana, Zwisler, Ann-Dorthe, Kjerholt, Mette, Flachs, Esben Meulengracht, Hasselbalch, Hans Carl, Andersen, Christen Lykkegaard

Journal:

Quality of Life Research

Year:

2016

Language:

english

File:

PDF, 1.33 MB

english, 2016

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски